Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. - Test2 - elhamkhani - TriplyDB

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

http://www.wikidata.org/entity/Q30447637

about

Age-related hearing impairment and the triad of acquired hearing loss.Prevention and restoration of hearing loss associated with the use of cisplatin.Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss.Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.Sesn2 gene ablation enhances susceptibility to gentamicin-induced hair cell death via modulation of AMPK/mTOR signaling.Severe hearing loss and outer hair cell death in homozygous Foxo3 knockout mice after moderate noise exposure.Cisplatin-Associated Ototoxicity: A Review for the Health Professional Electroacoustic stimulation: now and into the future Synaptopathy in the noise-exposed and aging cochlea: Primary neural degeneration in acquired sensorineural hearing loss.Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.Workplace Activity in Health Professionals Exposed to Chemotherapy Drugs: An Otoneurological Perspective Cisplatin exposure damages resident stem cells of the mammalian inner ear.Cockayne syndrome group B (Csb) and group a (Csa) deficiencies predispose to hearing loss and cochlear hair cell degeneration in mice.Factors Affecting the Variation of Maximum Speech Intelligibility in Patients With Sensorineural Hearing Loss Other Than Apparent Retrocochlear Lesions.Histone deacetylase inhibition protects hearing against acute ototoxicity by activating the Nf-κB pathway.Modeling of Auditory Neuron Response Thresholds with Cochlear Implants A partial hearing animal model for chronic electro-acoustic stimulation.Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.Characterizing human vestibular sensory epithelia for experimental studies: new hair bundles on old tissue and implications for therapeutic interventions in ageing.Tumor Necrosis Factor-α-Induced Ototoxicity in Mouse Cochlear Organotypic Culture.Epigenetic regulation in the inner ear and its potential roles in development, protection, and regeneration.Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway.Examination of the mode of action of the almiramide family of natural products against the kinetoplastid parasite Trypanosoma brucei.Activation of CHK1 in Supporting Cells Indirectly Promotes Hair Cell Survival [Etiologic profile of severe and profound sensorineural hearing loss in children in the region of north-central Morocco].Profiling drug-induced cell death pathways in the zebrafish lateral line.Aminoglycoside stress together with the 12S rRNA 1494C>T mutation leads to mitophagy.Using the zebrafish lateral line to uncover novel mechanisms of action and prevention in drug-induced hair cell death Gene transfection mediated by polyethyleneimine-polyethylene glycol nanocarrier prevents cisplatin-induced spiral ganglion cell damage.Survival of auditory hair cells.Pre-conditioning with near infrared photobiomodulation reduces inflammatory cytokines and markers of oxidative stress in cochlear hair cells.Natural Bizbenzoquinoline Derivatives Protect Zebrafish Lateral Line Sensory Hair Cells from Aminoglycoside Toxicity Canertinib induces ototoxicity in three preclinical models.Empirical antibiotic therapy for pneumonia in intensive care units: a multicentre, retrospective analysis of potentially pathogenic microorganisms identified by endotracheal aspirates cultures.Transient alteration of the vestibular calyceal junction and synapse in response to chronic ototoxic insult in rats d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models.Neuroglobin immunoreactivity in the human cochlea.Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.Evaluation of chemotherapeutic sequelae and quality of life in survivors of malignant sacrococcygeal teratoma.Pathophysiology of the cochlear intrastrial fluid-blood barrier (review).

P2860

Q26797403-3BF1789C-5764-4C37-93A7-1112F9C01ED1 Q26825493-ED207815-331E-45CA-A23E-A0145CC7C8D0 Q26851254-81F030AA-E1F8-42C3-B1A9-382281421E05 Q30240026-EEC47A08-CE07-448A-8451-E059008D412F Q30354894-983654D3-D9E2-4428-872D-F8010888AB0B Q30356371-35CD8357-8DD1-426D-85BF-CA4E6BAA4467 Q30365226-70BD156E-2CB9-4D1B-9DB9-A19D459313EB Q30367376-4B5CBC8B-3CB2-4501-8F1D-F1553C82D500 Q30368644-2F908596-0E3D-400B-A48D-4B836896DB57 Q30371605-DF30DA8B-9E84-405C-A6CC-322EA6350923 Q30372403-E95DFA92-4295-4322-B838-0B3DF7DE3F13 Q30401803-61859641-F540-490F-9E0E-60B27A1BF268 Q30403070-1CE70E0D-819F-44D3-945D-7A125E9366A8 Q30403664-341C6CE4-15A7-48D2-B8F0-F388BDC67E59 Q30404904-979A841C-3B21-455A-8C03-A67A637F98DC Q30405564-60E99E85-471B-4391-99DD-A3E153E52847 Q30405813-71DADCF4-D2BC-479D-ACA4-7B8E3E038728 Q30410332-2085731A-8B8D-4226-9662-85444D679582 Q30410492-7F0B4230-4E0E-4010-9E87-757A0111E24A Q30410865-D4AE2FEA-D711-42F5-8D45-35DADE27B31D Q30417109-07EF7A08-3473-4F37-AADB-62B8E377E3F6 Q30419038-085B92A0-8FE0-4ACC-8C63-7234D3A5BA36 Q30575091-0F86C41C-1B20-455D-AE24-E968D113AB31 Q33700754-CCC85D98-ADB1-4B79-8836-75E9B9B10260 Q33843349-C73C5D23-41EA-4CBA-B585-9DD74324BC20 Q34588145-A051D875-E694-4C2E-B6BA-437FC4143165 Q34634692-589F991A-E6A3-4990-970C-40FD7D156489 Q35094539-B8E4BA0D-56AA-4599-8C56-1FAF183EFCC8 Q35403464-10AB02A5-BE19-4153-9916-5C2204A1CCD0 Q35811898-B5C7C2F3-6F6F-4C34-9598-B9D8E7F97F4E Q35899190-1AB98E58-A9D0-4FFA-BFA7-C375C2CFD99A Q35986030-CFF36333-EE8D-42BF-9E21-332562DBCE7D Q36088986-94EB9D97-D1DC-4A42-9BCC-257D22818195 Q36167408-50A705A2-5E36-44A0-A816-C3CA7841002B Q36175380-470F206F-0BEA-40CC-A422-874EBF15D7C6 Q36446781-494ECD1F-C774-4041-939B-E288A6EB9019 Q37138326-85D23E83-C049-476D-B313-5B3D84A1395E Q37570413-1F41E1DB-BCF6-4A16-AFCC-20F82ED5CE7F Q38669182-26F7AFCC-FC2D-4845-A9FD-36484CC96A54 Q38708802-B0281F9B-5368-489B-AA15-79B13A43DE9C

P2860

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

http://www.wikidata.org/entity/Q30447637

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

@ast

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

@en

type

label

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

@ast

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

@en

prefLabel

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

@ast

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

@en

P1433

Q30447637-CC402E11-22DC-44D4-AB17-BE4A2BFD985F

P1476

Q30447637-14D2018A-669F-4885-B002-2B9E236478CE

P2093

Q30447637-19AEF73B-6129-4C7F-A29F-FD3B5159FE72

Q30447637-67A6EC92-C9D3-4FA4-9387-B15AF1567B4D

Q30447637-A38D2E99-9F1E-4FA9-8289-809BCCF54E71

P2860

Q30447637-00A1B38C-E57A-4595-BDAA-CA447BF5214B

Q30447637-00DE0A11-7AFC-49CD-952D-4D61BEF5536E

Q30447637-044F60EC-B025-41EE-BE0B-437B62E74BEF

Q30447637-04AACCF8-2327-4D33-806B-2D9286A16A5B

Q30447637-050F4846-1D87-40AD-81AF-2B7734C371A2

Q30447637-08245F11-F345-4FEA-A38A-312D8F53E5DE

Q30447637-08600779-B14B-430D-9932-DF95A01BC48A

Q30447637-08ED848D-7FF3-44BE-8BEC-068FB8342A1E

Q30447637-0A15714E-C1A3-4069-8777-34D5A47B202D

Q30447637-0A49EB7A-E609-4F9D-B259-2A078C7F8992

P304

Q30447637-4F203EC4-ED17-4FD2-ABC8-BEED6623BBEA

P31

Q30447637-71CE92DE-E852-413D-842B-6B8DE189273C

P356

Q30447637-6F212CE9-3190-4528-8FD1-58DA111588B0

P433

Q30447637-47162329-FBD0-4D56-BA5F-33AB83A5991C

P478

Q30447637-AA05684F-FFDB-45F5-91F3-44B30CB35413

P577

Q30447637-9C04A135-3AB3-488C-B328-BE8834C883BB

P5875

Q30447637-D7F8F910-31C0-4E94-9BE1-6EB6840487B6

P698

Q30447637-6DB87F68-D31B-4F68-8AF1-C238CB73044C

P921

Q30447637-448F84FA-9483-4AE2-B152-FE81CF1E81F6

P932

Q30447637-CA0014E1-2E1D-4F50-8CE4-9E4AE6CDC0FE

P356

P1433

The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology

P1476

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

@en

P2093

Andra E Talaska

http://www.w3.org/2001/XMLSchema#string

Jochen Schacht

http://www.w3.org/2001/XMLSchema#string

Leonard P Rybak

http://www.w3.org/2001/XMLSchema#string

P2860

A catechol-O-methyltransferase that is essential for auditory function in mice and humans.

Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity

Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin

Aspirin to prevent gentamicin-induced hearing loss

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Salicylate attenuates gentamicin-induced ototoxicity

Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation

Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage

Cellular processing of platinum anticancer drugs

P304

1837-1850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AR.22578

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

295

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232223393

http://www.w3.org/2001/XMLSchema#string

P698

23045231

http://www.w3.org/2001/XMLSchema#string

P921

P932

3596108

http://www.w3.org/2001/XMLSchema#string